These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35348578)

  • 1. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
    Li D; Lu Y; Yuan S; Cai X; He Y; Chen J; Wu Q; He D; Fang A; Bo Y; Song P; Bogaert D; Tsilidis K; Larsson SC; Yu H; Zhu H; Theodoratou E; Zhu Y; Li X
    Am J Clin Nutr; 2022 Jul; 116(1):230-243. PubMed ID: 35348578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
    Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
    Zhuang R; Ge X; Han L; Yu P; Gong X; Meng Q; Zhang Y; Fan H; Zheng L; Liu Z; Zhou X
    Obes Rev; 2019 Jun; 20(6):883-894. PubMed ID: 30868721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota-Derived Trimethylamine N-Oxide and Kidney Function: A Systematic Review and Meta-Analysis.
    Zeng Y; Guo M; Fang X; Teng F; Tan X; Li X; Wang M; Long Y; Xu Y
    Adv Nutr; 2021 Jul; 12(4):1286-1304. PubMed ID: 33751019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-dependent trimethylamine N-oxide and all-cause mortality: Findings from an updated systematic review and meta-analysis.
    Farhangi MA
    Nutrition; 2020 Oct; 78():110856. PubMed ID: 32592979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
    Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
    Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis.
    Abbasalizad Farhangi M; Vajdi M
    Nutr Rev; 2021 Aug; 79(9):1022-1042. PubMed ID: 33270896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel findings of the association between gut microbiota-derived metabolite trimethylamine
    Farhangi MA; Vajdi M
    Crit Rev Food Sci Nutr; 2020; 60(16):2801-2823. PubMed ID: 32462890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis.
    Ge X; Zheng L; Zhuang R; Yu P; Xu Z; Liu G; Xi X; Zhou X; Fan H
    Adv Nutr; 2020 Jan; 11(1):66-76. PubMed ID: 31269204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies.
    Zhang H; Yao G
    Eur J Clin Nutr; 2023 Jul; 77(7):731-740. PubMed ID: 35468932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
    Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis.
    Dehghan P; Farhangi MA; Nikniaz L; Nikniaz Z; Asghari-Jafarabadi M
    Obes Rev; 2020 May; 21(5):e12993. PubMed ID: 32017391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Sritara P; Phrommintikul A;
    Sci Rep; 2024 Sep; 14(1):21264. PubMed ID: 39261513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
    Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
    He M; Tan CP; Xu YJ; Liu Y
    Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
    Nowiński A; Ufnal M
    Nutrition; 2018 Feb; 46():7-12. PubMed ID: 29290360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
    Canyelles M; Borràs C; Rotllan N; Tondo M; Escolà-Gil JC; Blanco-Vaca F
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis.
    Han JM; Guo L; Chen XH; Xie Q; Song XY; Ma YL
    Medicine (Baltimore); 2024 Jan; 103(1):e36784. PubMed ID: 38181288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.